AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Silo Pharma Partners with Fireblocks to Enhance Crypto Treasury Security and Strategy
ByAinvest
Tuesday, Sep 23, 2025 8:23 am ET1min read
Silo Pharma has partnered with Fireblocks to secure its institutional crypto treasury platform. The partnership aims to ensure that the platform is built with enterprise-grade security and governance standards. Fireblocks has facilitated the secure transfer of over $6 trillion to date and offers custody solutions available to institutional clients. This partnership is part of Silo Pharma's cryptocurrency treasury strategy targeting multi-chain asset growth.
Silo Pharma Inc. (SILO) has announced a strategic partnership with Fireblocks, an enterprise platform for building blockchain applications and managing digital asset operations, to secure its institutional crypto treasury platform. The collaboration aims to ensure that the platform is built with enterprise-grade security and governance standards, leveraging Fireblocks' robust multi-layer security framework [1].The partnership is part of Silo Pharma's broader cryptocurrency treasury strategy, which targets multi-chain asset growth. Last week, the company announced its initial purchases of Ethereum (ETH) and Solana (SOL) tokens, marking the first step toward incorporating cryptocurrency into its treasury holdings [2]. This investment underscores the company's belief in the long-term value of digital assets and the potential of blockchain technology to shape the future of biotechnology.
Fireblocks, which has facilitated the secure transfer of over $6 trillion to date, offers custody solutions available to institutional clients. Its multi-layer security framework combines multi-party computation (MPC) technology, Intel SGX, a signature policy engine, and a deposit address authentication network, delivering custody solutions to exchanges, banks, payment service providers (PSPs), lending desks, custodians, trading desks, and hedge funds [1].
This partnership aligns with Silo Pharma's comprehensive digital assets strategy, which aligns with the accelerating adoption of digital assets by institutional investors and global enterprises. The company's forward-looking statements highlight the potential risks and uncertainties associated with this strategy, including changes in anticipated sources of revenues, future economic and competitive conditions, and difficulties in developing technology platforms [2].
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet